Branch duct intraductal papillary mucinous neoplasms: How ready are we to de-escalate surveillance?

doi:10.3748/wjg.v32.i19.115852

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 19

This Article

(44)

(38)

(1)

(0)

(1)

(34)

(2)

(3)

(655)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. May 21, 2026; 32(19): 115852
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115852

Full Size Figure Download Figure

Figure 2 Receiver operator characteristics plot showing the diagnostic ability of maximum cyst size and maximum cyst-fluid and serum cancer antigen 19-9 and carcinoembryonic antigen in predicting high grade dysplasia or malignancy. Cancer antigen 19-9 was additionally modelled for the diagnostic ability of the change in cancer antigen 19-9 (delta value) in predicting high grade dysplasia or malignancy. CA19-9: Cancer antigen 19-9; AUC: Area under the curve; CEA: Carcinoembryonic antigen.

Citation: Hopley PJ, Whelan P, Jackson R, Evans J, Andrews T, Ghaneh P, Raraty M, Greenhalf W, Halloran CM. Branch duct intraductal papillary mucinous neoplasms: How ready are we to de-escalate surveillance? World J Gastroenterol 2026; 32(19): 115852
URL: https://www.wjgnet.com/1007-9327/full/v32/i19/115852.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i19.115852

Hopley PJ, Whelan P, Jackson R, Evans J, Andrews T, Ghaneh P, Raraty M, Greenhalf W, Halloran CM. Branch duct intraductal papillary mucinous neoplasms: How ready are we to de-escalate surveillance? World J Gastroenterol 2026; 32(19): 115852 [DOI: 10.3748/wjg.v32.i19.115852]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.